FUREXEL COMBI ORAL PASTE
FUREXEL COMBI ORAL PASTE
Authorised
- Ivermectin
- Praziquantel
Product identification
Medicine name:
FUREXEL COMBI ORAL PASTE
Active substance:
- Ivermectin
- Praziquantel
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Ivermectin15.50/gram(s)1.00gram(s)
-
Praziquantel77.50/gram(s)1.00gram(s)
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal30day
-
Milkno withdrawal periodDo not use in mares producing milk for human consumption.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Luxembourg
Available in:
-
Luxembourg
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 344/00/12/0862
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0360/001
Concerned member states:
-
Belgium
-
Germany
-
Luxembourg
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 21/06/2022